Details for 2017177885

Up to date per 05.04.2026

Actions

Title / Product Name

OPTIMIERUNG VON ANTIKÖRPERN ZUR BINDUNG DES LYMPHOZYTENAKTIVIERUNGSGENS 3 (LAG-3) UND VERWENDUNGEN DAVON

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2017177885

EP Publication Number

3275899

E-Number

1306299

Language

PCT Number

Publication Date

31.01.2018 A

26.08.2020 B1

Registration Date

26.08.2020

AT Publication Date

15.09.2020

Application Date

02.07.2013

Registration Number

Priorities

02.07.2012

201261667058 P

IPC

C07K 16/28 20060101AFI20171113BHEP

Maximum Duration of Protection

02.07.2033

Owner

Bristol-Myers Squibb CompanyRoute 206 and Province Line Road Princeton, NJ 08543US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

LONBERG, Nilsc/o Bristol-Myers Squibb Company 700 Bay Road Redwood City, CA 94063US

SRINIVASAN, Mohanc/o Bristol-Myers Squibb Company 700 Bay Road Redwood City, CA 94063US

Information about Fees